Interviews with former Sprout employees, analysts, investors and doctors who helped bring the drug to
market suggest how a series of missteps after the deal, along with turbulence from
aggressive accounting practices, unusual business relationships and big egos, derailed one of the most intriguing new
pharmaceuticals in a generation.
Widely regarded sales and
marketing professional who quickly and efficiently achieves
aggressive growth targets in healthcare /
pharmaceutical industries.